Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.775 USD | +2.11% | +2.61% | -59.28% |
Chart calendar Bionano Genomics, Inc.
Upcoming events on Bionano Genomics, Inc.
Past events on Bionano Genomics, Inc.
2024-04-09 04:30 pm | American Association for Cancer Research Meeting - Abstract No:6257/27 |
2024-04-09 12:00 pm | American Association for Cancer Research Meeting - Abstract No:4895/20 |
2024-04-08 04:30 pm | American Association for Cancer Research Meeting - Abstract No:3551/11 |
2024-04-08 04:30 pm | American Association for Cancer Research Meeting - Abstract No:2860/16 |
2024-04-08 04:30 pm | American Association for Cancer Research Meeting - Abstract No:3492/14 |
2024-04-08 12:00 pm | American Association for Cancer Research Meeting - Abstract No:2012/28 |
2024-04-08 12:00 pm | American Association for Cancer Research Meeting - Abstract No:2271/12 |
2024-04-08 12:00 pm | American Association for Cancer Research Meeting - Abstract No:2337/15 |
2024-04-07 04:30 pm | American Association for Cancer Research Meeting - Abstract No:336/24 |
2024-03-14 10:30 am | American College of Medical Genetics and Genomics Clinical Genetics Meeting - Poster Number: P573 |
2024-03-06 12:50 pm | TD Cowen Health Care Conference |
2024-03-05 04:30 pm | Q4 2023 Earnings Call |
2024-03-05 04:01 pm | Q4 2023 Earnings Release |
2024-02-12 | BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference |
2023-12-11 09:00 pm | American Society of Hematology Meeting - Poster Number: 4612 |
2023-12-11 09:00 pm | American Society of Hematology Meeting - Poster Number: 4303 |
2023-12-11 09:00 pm | American Society of Hematology Meeting - Poster Number: 5039 |
2023-12-11 09:00 pm | American Society of Hematology Meeting - Poster Number: 5038 |
2023-12-11 09:00 pm | American Society of Hematology Meeting - Poster Number: 5024 |
2023-12-11 09:00 pm | American Society of Hematology Meeting - Poster Number: 4116 |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 10,1 11,8 -13.88% | 8,50 8,01 6.2% | 18,0 17,5 2.51% | 27,8 27,6 0.73% | 36,1 35,8 0.87% | 38,7 |
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | -122 -115 -5.74% | -202 -209 3.62% | -69,4 |
EBIT Million USD | Released Forecast Spread | -25,9 -25,1 -3.07% | -38,6 -35,5 -8.55% | -77,1 -68,0 -13.36% | -132 -124 -6.47% | -215 -223 3.43% | -87,2 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -29,8 -28,9 -3.26% | -41,1 -37,4 -9.77% | -78,2 -68,1 -14.72% | -131 -126 -3.65% | -232 -221 -5.23% | -87,7 |
Net income Million USD | Released Forecast Spread | -29,8 -28,9 -3.29% | -41,1 -37,9 -8.37% | -72,4 -94,0 22.93% | -133 -126 -5.09% | -232 -221 -5.22% | -87,7 |
EPS USD | Released Forecast Spread | -19,9 -20,8 4.1% | -3,90 -4,00 2.5% | -2,60 -3,40 23.53% | -4,60 -4,40 -4.55% | -6,81 -6,61 -2.97% | -1,90 |
Announcement Date | 05/03/20 | 23/03/21 | 01/03/22 | 09/03/23 | 05/03/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 6,30 5,85 7.72% | 5,70 5,68 0.32% | 6,67 6,28 6.16% | 7,22 6,79 6.28% | 8,22 8,01 2.58% | 7,42 7,22 2.68% | 8,66 8,31 4.3% | 9,32 9,08 2.58% | 10,7 10,4 2.95% | 8,49 | 9,07 | 9,73 | 11,5 | 11,0 |
EBITDA Million USD | Released Forecast Spread | -27,7 -27,2 -1.96% | -34,8 -29,8 -16.65% | -34,7 -31,0 -11.78% | -35,9 -28,6 -25.89% | -32,3 -27,8 -16.03% | -21,4 -27,2 21.34% | -20,4 | -18,2 | -16,7 | -14,2 | -15,0 | |||
EBIT Million USD | Released Forecast Spread | -28,8 -19,7 -46.42% | -29,9 -21,0 -42.28% | -32,1 -26,7 -20.18% | -32,1 -32,1 -0.22% | -37,5 -31,0 -20.96% | -37,8 -31,0 -22.14% | -39,2 -31,8 -23.25% | -35,9 -32,9 -9.12% | -25,0 -32,6 23.46% | -24,9 | -23,1 | -20,8 | -18,4 | -21,3 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -28,7 -18,7 -53.66% | -29,9 -20,3 -47.68% | -32,1 -24,9 -29.05% | -31,8 -31,5 -0.97% | -36,9 -32,3 -14.2% | -37,1 -32,4 -14.45% | -38,9 -32,7 -19.04% | -113 -32,7 -244.2% | -43,9 -32,3 -35.89% | -25,0 | -23,2 | -20,9 | -18,6 | -21,6 |
Net income Million USD | Released Forecast Spread | -22,9 -44,5 48.42% | -30,0 -21,0 -42.59% | -32,2 -26,6 -20.78% | -31,8 -32,1 0.84% | -38,7 -32,3 -19.79% | -37,1 -32,4 -14.53% | -38,9 -32,7 -19.14% | -113 -32,7 -244.31% | -43,9 -32,3 -35.78% | -25,0 | -23,2 | -20,9 | -18,6 | -21,6 |
EPS USD | Released Forecast Spread | -0,80 -1,50 46.67% | -1,10 -0,83 -32% | -1,10 -0,90 -22.22% | -1,10 -1,13 2.94% | -1,30 -1,10 -18.18% | -1,20 -1,10 -9.09% | -1,24 -1,08 -15.35% | -3,22 -1,03 -214.15% | -0,96 -0,87 -10.34% | -0,65 | -0,50 | -0,45 | -0,38 | -0,48 |
Announcement Date | 01/03/22 | 05/05/22 | 04/08/22 | 03/11/22 | 09/03/23 | 09/05/23 | 09/08/23 | 08/11/23 | 05/03/24 | - | - | - | - | - |
2024-04-26 | SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: Q1 2024 Earnings Release |
2024-04-26 | SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: Q4 2023 Earnings Release |
2024-04-29 01:00 am | PHILIPS NV: Q1 2024 Earnings Release |
2024-04-29 06:00 am | REVVITY, INC.: Q1 2024 Earnings Release |
2024-04-30 06:20 am | GE HEALTHCARE TECHNOLOGIES INC.: Q1 2024 Earnings Release |
2024-04-30 04:05 pm | TRANSMEDICS GROUP, INC.: Q1 2024 Earnings Release |
2024-05-01 | INMODE LTD.: Q1 2024 Earnings Release |
2024-05-02 07:00 am | BRUKER CORPORATION: Q1 2024 Earnings Release |
2024-05-02 04:01 pm | HOLOGIC, INC.: Q2 2024 Earnings Release |
2024-05-02 04:05 pm | LEMAITRE VASCULAR, INC.: Q1 2024 Earnings Release |
Past sector events for Bionano Genomics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BNGO Stock
- Calendar Bionano Genomics, Inc.